Berry Street and Healthify merge as AI meets traditional clinics to keep pace with the weight-loss drug boom

U.S. nutrition company “Berry Street” announced its merger with Indian firm “Healthify,” which specializes in AI-powered nutritional guidance, in a strategic move aimed at directly capitalizing on the rapid surge in demand for GLP-1 weight-loss drugs. While the financial terms of the deal were not disclosed, the new entity is launching based on estimates from JPMorgan that more than 30 million people in the United States will be using this drug class by 2030, prompting a shift in the metabolic-care system and daily monitoring.

Under the merger agreement, Noah Kotlov, founder of Berry Street, and Tushar Vashisht, founder of Healthify, will share leadership as co-CEOs of the combined entity. The entity will operate in the U.S. market under the “Berry Street” brand, while continuing in India and other international markets under the “Healthify” name. The Indian company, backed by “Khosla Ventures,” which has raised over $150 million, has a user base exceeding 45 million customers for hybrid sports and nutrition guidance services that combine human coaches with intelligent algorithms.

In contrast, Berry Street offers a clinical platform that includes a network of more than two thousand clinics and provides insurance-covered care programs for GLP-1 drug recipients, after raising $50 million last year in a funding round led by North Zone, Sofina and FGH Labs. According to the company, its smart meal-tracking and nutrition-guidance system has served over 200 thousand users through partnerships with major retail platforms such as Amazon and Walmart, reflecting the alliance’s aim toBuilding a platform that redefines metabolic care by linking AI to an accredited clinic network.

This alliance reveals a pivotal shift in the economics of health technology, asIsolated digital applications are no longer sufficient to keep pace with advanced drug-treatment protocols.without a direct link to clinical infrastructure and insurance coverage. Conversely, traditional clinic networks find smart follow-up algorithms a necessary tool to broaden nutritional oversight of patients beyond direct visit times, thereby increasing the efficiency of medical interventions and reducing operational burdens on human staff.

For the health-care and tech sector in the Gulf and Egypt, this model has a direct operational impact on health-insurance companies and medical platform developers. As the adoption of weight-management therapies grows locally, competition shifts from merely providing apps or selling drugs to designing hybrid care pathways that combine smart monitoring with clinical insurance coverage. This reality forces regional startups to reshape their products, either by partnering with local clinics to secure accredited insurance channels or by integrating advanced tracking solutions that ensure patient compliance and lower long-term care costs.